NeuroPace (NPCE) Share-based Compensation Growth (3y) (2023 - 2026)
NeuroPace (NPCE) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.40% |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | -4.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.63% |
| Mar 31, 2026 | 6.43% |
| Dec 31, 2025 | 26.81% |
| Sep 30, 2025 | -82.87% |
| Jun 30, 2025 | -15.56% |
| Mar 31, 2025 | 20.85% |
| Dec 31, 2024 | -53.05% |
| Jun 30, 2024 | 188.35% |
| Mar 31, 2024 | 47.56% |
| Dec 31, 2023 | -153.31% |
| Sep 30, 2023 | 100.36% |
| Jun 30, 2023 | 151.88% |
| Mar 31, 2023 | -21.43% |